Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Annals of Surgical Oncology|February 14, 2015
Negative Sentinel Lymph Node Biopsy in Merkel Cell Carcinoma is Associated with a Low Risk of Same-Nodal-Basin RecurrencesTravis E Grotz, Richard W Joseph, Barbara A Pockaj, et al.
European Urology|January 7, 2014
Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinomaAlexander S Parker, Jeanette E Eckel-Passow, Daniel Serie, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 15, 2020
Health-related quality of life (QoL) in patients with advanced melanoma receiving immunotherapies in real-world clinical practice settingsRichard W Joseph, Frank Xiaoqing Liu, Alicia C Shillington, et al.
Human Immunology|May 3, 2012
Vitamin D receptor upregulation in alloreactive human T cellsRichard W Joseph, Ulas D Bayraktar, Tae Kon Kim, et al.
Cancer|January 3, 2014
Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinomaRichard W Joseph, Payal Kapur, Daniel J Serie, et al.
Surgical Oncology|March 19, 2018
Sentinel lymph node biopsy in Merkel cell carcinoma: The Mayo Clinic experience of 150 patientsJohn R Sims, Travis E Grotz, Barbara A Pockaj, et al.
Clinical Genitourinary Cancer|October 25, 2016
A Study of Combination Bicalutamide and Raloxifene for Patients With Castration-Resistant Prostate CancerThai H Ho, Rafael Nunez-Nateras, Yue-Xian Hou, et al.
European Urology|December 1, 2016
Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and AggressivenessDaniel J Serie, Richard W Joseph, John C Cheville, et al.
Cancer Immunology Research|February 4, 2014
Severe cutaneous and neurologic toxicity in melanoma patients during vemurafenib administration following anti-PD-1 therapyDouglas B Johnson, Erika K Wallender, Daniel N Cohen, et al.
Cancer Immunology Research|August 27, 2015
PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid DifferentiationRichard W Joseph, Sherri Z Millis, Estrella M Carballido, et al.
Pageof 9